In test-tube studies, alpha-lipoic acid has reduced markers of inflammation, including NF-kB, ICAM-1, VCAM-1, MMP-2, MMP-9, and IL-6 ( May lower heart disease risk factors Heart disease is responsible for one in four deaths in America ( Research from a combination of lab, animal, and human studies has shown that the antioxidant properties of alpha-lipoic acid may lower several heart disease risk factors
The EU5 public healthcare systems also reimburse GLP-1s, but often with prescribing restrictions such as specialist approval or use only as 3rd line treatment at the earliest, which limits penetration
Peptide degradation produces fragments and aggregates that may trigger immune responses
Going off the medication could mean a return of appetite, cravings and weight gain